Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
基本信息
- 批准号:6399858
- 负责人:
- 金额:$ 26.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-04 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assay actins athymic mouse bone neoplasms brain neoplasms breast neoplasms cadherins connective tissue stroma differential display technique enzyme induction /repression gelsolin immunocytochemistry laboratory rat liver neoplasms lung neoplasms metalloendopeptidases metastasis neoplasm /cancer invasiveness polymerase chain reaction pregnancy vimentin
项目摘要
DESCRIPTION (provided by applicant): The relationship between reproductive
history and breast cancer is complex. A full term pregnancy in younger women is
protective against breast cancer later in life, while a first full term
pregnancy after 40 years of age is associated with higher cancer occurrence. In
addition, there is an increase in breast cancer within the first two years of
pregnancy, regardless of age. Pregnancy associated breast cancer also presents
at a later clinical stage and is more invasive than non-pregnancy associated
breast cancers. We hypothesize that the cancer promotional effect of pregnancy
is due to physiologic remodeling of the mammary stroma that occurs after
pregnancy. During parturition or weaning-induced mammary gland involution,
mammary stroma is degraded and stroma levels of matrix metalloproteinases (MMP)
and pro-inflammatory mediators are elevated. We propose that these
involution-associated changes in mammary stroma promote an epithelial to
mesenchymal transition (EMT) in pre-existing neoplastic cells. The resulting
activated tumor cells, coupled with the weakened stromal barrier, increases the
likelihood of tumor cell extravasation. Since the likelihood of having occult
tumor cells increases with age, pregnancy associated gland involution is more
likely to effect EMT and metastases in older women. In Aim 1. the hypothesis
that tumor cell metastatic potential is modulated by reproductive status will
be tested in vivo using xenograft models. Human mammary tumor cells will be
injected directly into teats or mammary fat pads of immunodeficient mice at
different reproductive stages (i.e. nulliparous, 'pregnancy-associated', and
parous). The ability of tumor cells to exit the gland is predicted to be
dependent on the degree of tissue remodeling at the time of injection: low in
nulliparous and parous, and high in regressing glands. Primary tumors will be
evaluated histologically and metastases to lung, liver, brain and long bone of
the leg will be measured by semi-quantitative PCR using a unique human
sequence, the CCR5 gene. In Aim 2, the hypothesis that endocrine-induced
changes in stroma composition can either promote or suppress EMT will be
evaluated in vitro using reconstitution models. Human mammary epithelial cells,
which differ in metastatic potential from non-tumorigenic to metastatic, will
be combined with mammary stroma isolated from rats with different reproductive
states. It is anticipated that quiescent mammary stroma (nulliparous and
parous) will inhibit, while involuting matrix will promote EMT in highly
metastatic cells. Functional evidence for EMT will be obtained by measuring
stroma-dependent changes in cell adhesion, motility and invasiveness using
modified Boyden chambers assays. Morphological and biochemical evidence for EMT
will be evaluated in a 3-dimensional model of tumor formation. The effects of
mammary matrix on key markers of EMT, actin fiber organization, and expression
of E-cadherin, vimentin, gelsolin and Fspl proteins, will be determined
biochemically. In Aim 3, the hypothesis that involuting mammary matrix induces,
while nulliparous and parous mammary matrices suppress expression of MMP in
tumor cells will be evaluated by reporter gene assays. Luciferase-based
reporter constructs containing either the stromelysin (MMP-3), gelatinase A
(MMP-2), or gelatinase B (MMP-9) promoters will be tested for activity in tumor
cells plated on different mammary matrices. The results of these studies will
contribute to our understanding of the effects pregnancy-associated changes in
mammary stroma have on breast cancer progression, and should provide insights
into epidemiological data describing the dual effect of pregnancy on breast
cancer.
说明(由申请人提供):生育关系
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pepper J Schedin其他文献
Pepper J Schedin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pepper J Schedin', 18)}}的其他基金
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
- 批准号:
10113546 - 财政年份:2013
- 资助金额:
$ 26.62万 - 项目类别:
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
- 批准号:
10372923 - 财政年份:2013
- 资助金额:
$ 26.62万 - 项目类别:
NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention
产后复健期间使用非甾体抗炎药进行乳腺癌化学预防
- 批准号:
10588231 - 财政年份:2013
- 资助金额:
$ 26.62万 - 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
- 批准号:
6514478 - 财政年份:2001
- 资助金额:
$ 26.62万 - 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
- 批准号:
6752376 - 财政年份:2001
- 资助金额:
$ 26.62万 - 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
- 批准号:
7287605 - 财政年份:2001
- 资助金额:
$ 26.62万 - 项目类别:
Endocrine Status of MG Stroma Alters Breast CA Invasion
MG 基质的内分泌状态改变乳腺 CA 侵袭
- 批准号:
6633698 - 财政年份:2001
- 资助金额:
$ 26.62万 - 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
- 批准号:
2429908 - 财政年份:1996
- 资助金额:
$ 26.62万 - 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
- 批准号:
2114691 - 财政年份:1996
- 资助金额:
$ 26.62万 - 项目类别:
ECM MEDIATORS OF CHEMOPREVENTIVE AGENTS IN THE BREAST
乳房化学预防剂的 ECM 介质
- 批准号:
2895550 - 财政年份:1996
- 资助金额:
$ 26.62万 - 项目类别:
相似海外基金
A novel motility system driven by two classes of bacterial actins MreB
由两类细菌肌动蛋白 MreB 驱动的新型运动系统
- 批准号:
22KJ2613 - 财政年份:2023
- 资助金额:
$ 26.62万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The structural basis of plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
342887 - 财政年份:2016
- 资助金额:
$ 26.62万 - 项目类别:
Operating Grants
The structural basis for plasmid segregation by bacterial actins
细菌肌动蛋白分离质粒的结构基础
- 批准号:
278338 - 财政年份:2013
- 资助金额:
$ 26.62万 - 项目类别:
Operating Grants
Cytoplasmic Actins in Maintenance of Muscle Mitochondria
细胞质肌动蛋白在维持肌肉线粒体中的作用
- 批准号:
8505938 - 财政年份:2012
- 资助金额:
$ 26.62万 - 项目类别:
Differential Expression of the Diverse Plant Actins
多种植物肌动蛋白的差异表达
- 批准号:
7931495 - 财政年份:2009
- 资助金额:
$ 26.62万 - 项目类别:
Studies on how actins and microtubules are coordinated and its relevancy.
研究肌动蛋白和微管如何协调及其相关性。
- 批准号:
19390048 - 财政年份:2007
- 资助金额:
$ 26.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Interaction of myosin with monomeric actins
肌球蛋白与单体肌动蛋白的相互作用
- 批准号:
5311554 - 财政年份:2001
- 资助金额:
$ 26.62万 - 项目类别:
Priority Programmes
STRUCTURE/INTERACTIONS OF ACTINS AND ACTIN-BINDING PROTEIN
肌动蛋白和肌动蛋白结合蛋白的结构/相互作用
- 批准号:
6316669 - 财政年份:2000
- 资助金额:
$ 26.62万 - 项目类别:














{{item.name}}会员




